These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7912440)

  • 1. Synthesis and pharmacological evaluation of some potential beta-adrenolytics derivated from o-hydroxyacetophenone.
    Cizmáriková R; Racanská E; Dingová A; Greksáková O
    Pharmazie; 1994 May; 49(5):366-7. PubMed ID: 7912440
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalent ligand type beta-adrenolytics related to practolol.
    Rampa A; Da Re P; Valenti P; Frigeni V; Sala R; Della Bella D
    Drugs Exp Clin Res; 1988; 14(9):581-6. PubMed ID: 2906585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-specific actions of p-hydroxypropiophenones--potential beta adrenolytics].
    Cizmáriková R; Mlynarcík D; Greksáková O; Racanská E
    Pharmazie; 1990 Feb; 45(2):142-3. PubMed ID: 1971116
    [No Abstract]   [Full Text] [Related]  

  • 5. [Derivatives of para-hydroxyacetophenone and para-hydroxypropiophenone as a potential new beta-adrenolytic agent].
    Cizmáriková R; Dingová A; Kozlovský J; Greksáková O
    Cesk Farm; 1990 Nov; 39(9):403-8. PubMed ID: 1982858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in basic nitrogen in a group of potential new beta- adrenolytics--derivatives of p-hydroxyacetophenone and p-hydroxypropiofenone].
    Cizmáriková R; Racanská E; Greksáková O
    Cesk Farm; 1993 Apr; 42(2):82-5. PubMed ID: 8104716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, local anaesthetic and antiarrhythmic activity of pyrrolidinomethylcyclohexyl esters of alkoxysubstituted phenylcarbamic acids.
    Búciová L; Cizmárik J; Sedlárová E; Racanská E
    Pharmazie; 1995 Aug; 50(8):566-7. PubMed ID: 7568323
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacologic evaluation of p-hydroxyacetophenone derivatives as potential beta-adrenolytics].
    Racanská E; Kozlovský J
    Ceska Slov Farm; 1994 Jul; 43(4):169-70. PubMed ID: 7915177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of beta-adrenolytics on the isolated guinea-pig atria.
    Grodzińska L; Gryglewski R
    Arch Int Pharmacodyn Ther; 1971 May; 191(1):133-41. PubMed ID: 4397624
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on a new 1,5-benzothiazepine derivative (CRD-401). V. Antiarrhythmic actions.
    Yamada K; Shimamura T; Nakajima H
    Jpn J Pharmacol; 1973 Jun; 23(3):321-8. PubMed ID: 4146776
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological evaluation of new alkylesters of 4-[(2-hydroxy-3-alkylamino)propoxy]phenylcarbamic acids with beta-adrenolytic properties.
    Racanská E; Csöllei J; Svec P
    Pharmazie; 1990 Nov; 45(11):851-3. PubMed ID: 1983125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
    Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
    [No Abstract]   [Full Text] [Related]  

  • 13. Syntheses of the optical isomers of befunolol.HCl and their beta-adrenergic blocking activities.
    Nakano J; Mimura M; Hayashida M; Fujii M; Kimura K; Nakanishi T
    Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1399-403. PubMed ID: 2901296
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
    Laubie M; Cheymol G; Mouillé P; Gilbert JC; Schmitt H
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):323-33. PubMed ID: 4146788
    [No Abstract]   [Full Text] [Related]  

  • 16. [Search for new beta-adrenoblockaders among derivatives of (3-amino-2-hydroxypropoxy) phenoxymethyl isoxazole].
    Iuzhakov SD; Sokolov SD; Vinogradova SM
    Farmakol Toksikol; 1988; 51(4):47-52. PubMed ID: 2903834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of dl-5-methyl-8-(2-hydroxy-3-t-butylaminopropoxy) coumarin hydrochloride (CS-359), a new beta-adrenergic blocking agent.
    Oshima T; Kumakura S; Koike H; Nakayama K
    Jpn J Pharmacol; 1973 Aug; 23(4):497-513. PubMed ID: 4148384
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contribution to the pharmacology of the beta-adrenolytics].
    Wagner J
    Dtsch Med Wochenschr; 1970 Nov; 95(48):2442-8. PubMed ID: 4394708
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of different drugs with beta-adrenolytic activity on experimental models of arrhythmias.
    Marmo E
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(2):231-47. PubMed ID: 4397723
    [No Abstract]   [Full Text] [Related]  

  • 20. Arrhythmias and antiarrhythmic drugs: mechanism of action and structure-activity relationships II.
    Morgan PH; Mathison IW
    J Pharm Sci; 1976 May; 65(5):635-48. PubMed ID: 6770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.